Publication Name	World Journal of Gastroenterology
Manuscript ID	9778
Country	China

Received	2014-02-27 14:17
Peer-Review Started	2014-02-27 21:13
First Decision by Editorial Office Director
Return for Revision	2014-04-27 12:18
Revised	2014-05-12 03:25
Publication Fee Transferred
Second Decision by Editor	2014-06-13 16:01
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-06-13 16:09
Articles in Press	2014-06-13 16:27
Edit the Manuscript by Language Editor	2014-07-03 21:12
Typeset the Manuscript	2014-09-27 14:59
Publish the Manuscript Online	2014-10-20 18:35

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Complete response to sorafenib in a patient with recurrent hepatocellular carcinoma
Manuscript Source	Unsolicited Manuscript
All Author List	Hong-Bo Huan, Wan-Yee Lau, Feng Xia, Kuan-Sheng Ma and Ping Bie
Funding Agency and Grant Number
Corresponding Author	Feng Xia, MD, PhD, Institute of Hepatobiliary Surgery, Southwest Hospital, Southwest Cancer Center, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China. txzzxf@163.com
Key Words	Hepatocellular carcinoma; Partial hepatectomy; Sorafenib; Complete response
Core Tip	For patients with multiple recurrent hepatocellular carcinoma (HCC) after partial hepatectomy which cannot be treated by re-hepatectomy or local ablative therapy, the prognosis is extremely poor. Our case showed that the patient with recurrent HCC treated with sorafenib can achieve a complete clinical response as it did in advanced HCC.
Publish Date	2014-10-20 18:35
Citation	Huan HB, Lau WY, Xia F, Ma KS, Bie P. Complete response to sorafenib in a patient with recurrent hepatocellular carcinoma. World J Gastroenterol 2014; 20(39): 14505-14509
URL	http://www.wjgnet.com/1007-9327/full/v20/i39/14505.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i39.14505

Full Article (PDF)	WJG-20-14505.pdf
Full Article (Word)	WJG-20-14505.doc
Manuscript File	9778-Review.doc
Answering Reviewers	9778-Answering reviewers.pdf
Copyright License Agreement	9778-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	9778-Language certificate.pdf
Peer-review Report	9778-Peer review(s).pdf
Scientific Misconduct Check	9778-CrossCheck.jpg
Scientific Editor Work List	9778-Scientific editor work list.pdf